AmpliPhi Biosciences (APHB) Reports Data From Phase 1 Trial of AB-SA01 Targeting S. Aureus Infections
Go back to AmpliPhi Biosciences (APHB) Reports Data From Phase 1 Trial of AB-SA01 Targeting S. Aureus Infections| Ampliphi Biosciences Corporation (NYSE: APHB) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $6.12 | |||
| Open | $5.56 | 52 Week Low | $0.89 | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $0.00 | |||
| Volume | 16,700 | |||||
